文献速递认知障碍与痴呆帕金森病与运动障碍

痴呆伴路易小体、阿尔茨海默病与帕金森病早期表现比较:来自常规初级保健与英国生物银行数据的证据

A Comparison Between Early Presentation of Dementia with Lewy Bodies, Alzheimer's Disease, and Parkinson's Disease: Evidence from Routine Primary Care and UK Biobank Data.
PubMed 文献 · Ann Neurol · 2023-05-11

基于英国THIN纵向数据库,比较28,222例帕金森病、20,214例阿尔茨海默病、4,682例痴呆伴路易小体患者与20,214名健康对照在诊断前的临床特征,并在英国生物银行中重复主要发现。结果显示跌倒、精神症状和自主神经功能障碍与痴呆伴路易小体的关联强于帕金森病和阿尔茨海默病,他汀使用在帕金森病中较低、在痴呆伴路易小体中较高。

要点

  • 跌倒、精神症状和自主神经功能障碍在诊断前5年与痴呆伴路易小体的关联强于帕金森病和阿尔茨海默病。
  • 他汀使用在帕金森病患者中较低、在痴呆伴路易小体患者中较高,均与阿尔茨海默病患者相比。
  • 帕金森病患者中,他汀使用与帕金森病诊断后5年内发生痴呆相关。

核心结论

  • 诊断前出现的跌倒、精神症状和自主神经功能障碍与痴呆伴路易小体的关联强于帕金森病和阿尔茨海默病。
  • 多种药物关联在神经退行性疾病间相似,但他汀使用与帕金森病呈负相关,与痴呆伴路易小体、阿尔茨海默病以及帕金森病中痴呆的发生呈正相关。

研究设计与样本

  • 使用英国THIN纵向数据库,检验每种神经退行性疾病与所选症状及大类治疗之间的关联,并比较疾病间关联以识别疾病特异性效应。
  • 在UK Biobank中重复主要发现。
  • 纳入28,222例帕金森病、20,214例阿尔茨海默病、4,682例痴呆伴路易小体和20,214名健康对照。

主要发现

  • 所有神经退行性疾病在诊断前均与多种临床特征显著相关,包括睡眠障碍、跌倒、精神症状和自主神经功能障碍。
  • 在首次神经退行性疾病诊断前5年内,跌倒、精神症状和自主神经功能障碍与痴呆伴路易小体的关联均强于帕金森病和阿尔茨海默病。
  • 与阿尔茨海默病患者相比,他汀使用在发展为帕金森病的患者中较低、在发展为痴呆伴路易小体的患者中较高。
  • 在帕金森病患者中,他汀使用与帕金森病诊断后5年内发生痴呆相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose of this study was to simultaneously contrast prediagnostic clinical characteristics of individuals with a final diagnosis of dementia with Lewy Bodies (DLB), Parkinson's disease (PD), and Alzheimer's disease (AD) compared with controls without neurodegenerative disorders. METHODS: Using the longitudinal THIN database in the United Kingdom, we tested the association of each neurodegenerative disorder with a selected list of symptoms and broad families of treatments, and compared the associations between disorders to detect disease-specific effects. We replicated the main findings in the UK Biobank. RESULTS: We used data of 28,222 patients with PD, 20,214 with AD, 4,682 with DLB, and 20,214 healthy controls. All neurodegenerative disorders were significantly associated with the presence of multiple clinical characteristics before their diagnosis, including sleep disorders, falls, psychiatric symptoms, and autonomic dysfunctions. When comparing patients with DLB with patients with PD and patients with AD patients, falls, psychiatric symptoms, and autonomic dysfunction were all more strongly associated with DLB in the 5 years preceding the first neurodegenerative diagnosis. The use of statins was lower in patients who developed PD and higher in patients who developed DLB compared to patients with AD. In patients with PD, the use of statins was associated with the development of dementia in the 5 years following PD diagnosis. INTERPRETATION: Prediagnostic presentations of falls, psychiatric symptoms, and autonomic dysfunctions were more strongly associated with DLB than PD and AD. This study also suggests that although several associations with medications are similar in neurodegenerative disorders, statin usage is negatively associated with PD but positively with DLB and AD as well as development of dementia in PD. ANN NEUROL 2023;94:259-270.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Nedelec T, Couvy-Duchesne B, Darves-Bornoz A, et al. A Comparison Between Early Presentation of Dementia with Lewy Bodies, Alzheimer's Disease, and Parkinson's Disease: Evidence from Routine Primary Care and UK Biobank Data. Ann Neurol. 2023. PMID: 37098633. doi:10.1002/ana.26670

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。